Lucid Diagnostics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Lucid Diagnostics has a total shareholder equity of $16.0M and total debt of $11.2M, which brings its debt-to-equity ratio to 70.1%. Its total assets and total liabilities are $34.1M and $18.1M respectively.
Anahtar bilgiler
70.1%
Borç/özkaynak oranı
US$11.20m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$26.28m |
| Eşitlik | US$15.98m |
| Toplam yükümlülükler | US$18.13m |
| Toplam varlıklar | US$34.11m |
Son finansal sağlık güncellemeleri
Recent updates
We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
May 09
Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely
Dec 15Lucid Diagnostics launches stage II lucid test center in California, Texas, Florida, and Ohio
Aug 11We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate
Jul 07Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: LUCD's short term assets ($27.9M) exceed its short term liabilities ($16.0M).
Uzun Vadeli Yükümlülükler: LUCD's short term assets ($27.9M) exceed its long term liabilities ($2.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: LUCD has more cash than its total debt.
Borcun Azaltılması: LUCD's debt to equity ratio has increased from 0% to 70.1% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: LUCD has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: LUCD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 41.8% each year